Heart transplantation in adults with end-stage congenital heart disease

Luke J. Burchill, Heather J. Ross

    Research output: Contribution to journalReview articlepeer-review

    14 Scopus citations


    Residual abnormalities in cardiac structure and function predispose adults with congenital heart disease to late-onset heart failure and its complications. Evaluation of this population requires collaboration between adult congenital and heart failure specialists. In addition to assessing heart transplant eligibility, clinicians must balance the risks of premature listing against progressive heart failure and increased waiting list mortality. Following heart transplantation, adults with congenital heart disease have higher mortality due to an increased risk of bleeding, infection and donor right heart failure secondary to pulmonary hypertension. Concerns relating to increased early mortality should be balanced against superior long-term survival in adult congenital heart disease patients surviving beyond the first year after heart transplantation.

    Original languageEnglish (US)
    Pages (from-to)329-342
    Number of pages14
    JournalFuture Cardiology
    Issue number2
    StatePublished - Mar 2012


    • Fontan
    • adult congenital heart disease
    • heart failure
    • risk stratification
    • sudden cardiac death
    • transplantation

    ASJC Scopus subject areas

    • Molecular Medicine
    • Cardiology and Cardiovascular Medicine


    Dive into the research topics of 'Heart transplantation in adults with end-stage congenital heart disease'. Together they form a unique fingerprint.

    Cite this